affecting lipoprotein traits, defined as plasma concentrations of TG, high-density lipoprotein (HDL) and low-density lipoprotein (LDL) cholesterol, can give biological insight into both new and old pathways of lipid metabolism. These findings will have potential implications for the diagnosis, prognosis and treatment of dyslipidemia. In the last two decades, the rare genetic variants responsible for many individually rare dyslipidemia conditions have been discovered and common variation in many candidate genes has been tested for association with lipoprotein traits. However, in the last year, 10 genome-wide association studies (GWASs) have consistently identified association between common genetic variation in multiple novel, as well as previously known, genes and lipoprotein traits in normolipidemic individuals
Plasma lipids, including cholesterol and triglyceride (TG), play vital roles in cell membrane fluidity, hormone and bile synthesis, and energy metabolism. The identification of genetic variants affecting lipoprotein traits, defined as plasma concentrations of TG, high-density lipoprotein (HDL) and low-density lipoprotein (LDL) cholesterol, can give biological insight into both new and old pathways of lipid metabolism. These findings will have potential implications for the diagnosis, prognosis and treatment of dyslipidemia. In the last two decades, the rare genetic variants responsible for many individually rare dyslipidemia conditions have been discovered and common variation in many candidate genes has been tested for association with lipoprotein traits. However, in the last year, 10 genome-wide association studies (GWASs) have consistently identified association between common genetic variation in multiple novel, as well as previously known, genes and lipoprotein traits in normolipidemic individuals (1) (2) (3) (4) (5) (6) (7) (8) (9) (10) . The identification of loci with previous evidence for roles in lipoprotein metabolism, such as association between the gene for apolipoprotein E (APOE) and LDL, serve as a positive control for the approach, while many new associations between lipoproteins and genes without a priori hypotheses were also uncovered (1) (2) (3) (4) (5) (6) (7) (8) (9) (10) . In total, 40 loci have been associated at a GWAS significance level with at least one of TG, HDL, or LDL (Supplementary Table 1 ). Of note, in 13 of 15 genes previously identified to contain rare mutations causative for Mendelian lipid abnormalities, common SNP variation within the same gene has been associated with the same lipid fraction that is primarily disturbed in the Mendelian disease. An important next step is replication of the findings in multiple ethnicities, both to ensure the findings are generalizable and to further delineate the effect size and location of the causative variants.
This study set out to replicate the previously identified GWAS findings in a multiethnic population based sample.
As microarray technology improves, the density of the arrays, or the number of SNPs evaluated on a single chip, increases in number. The improved density presents two possibilities: denser SNP coverage of the human genome or the ability to genotype multiple individuals on the same chip. The by guest, on August 15, 2017 www.jlr.org
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Illumina Human CVD beadchip uses the second approach, using multiple "wells" to interrogate ~50,000
SNPs in 12 individuals on a single array (11) . The SNPs were selected for inclusion on the human CVD beadchip based on: 1) early access to lipid, lipoprotein and cardiovascular disease (CVD) GWAS results, 2) established quantitative trait loci in CVD, 3) genes with a functional link to CVD, and 4) a heavy bias for tagSNPs, non-synonymous SNPs, and SNPs with known function (11) . The selection criteria created a pool of SNPs with a higher prior probability of association, reducing both the false discovery rate (FDR) and the cost per sample. Permutation analysis has been suggested as a more appropriate method to correct for multiple testing (12), but has not become standard practice for GWAS, at least partially due to the computational requirements.
We sought to replicate reported genetic associations with fasting TG, HDL, and LDL using ~50 000 SNPs in ~2100 genes in a multiethnic population-based sample using the new Illumina CVD beadchip microarray and perform large-scale permutation analysis to improve signal-to-noise ratio and correct for multiple testing.
METHODS

Study subjects
The study was approved by the ethics boards of McMaster University and the University of Western Ontario. All participants provided informed consent for DNA analysis. The Study of Health Assessment and Risk in Ethnic Groups (SHARE) population was collected as a random prospective population sample of in Hamilton, Toronto, and Edmonton as previously described (13) . Individuals were classified as South Asian (n = 330) if their ancestors originated from India, Pakistan, Sri Lanka, or Bangladesh; Chinese (n = 304) if their ancestors originated from China, Taiwan, or Hong Kong; and European (n = 272) if their ancestors originated from Europe (13) Figure 3 for trait distributions). Sixty-seven individuals (7.4%) were on lipid lowering therapy and were excluded from further analysis.
Biochemical analyses
Genomic DNA was extracted from leukocytes as previously described (14) . Whole genomic DNA was checked for quality by 1.5% agarose gel electrophoresis. DNA was diluted to 50 to 70 ng/ul and the concentration was verified using a Nanodrop spectrophotometer. Standard protocols for hybridization and scanning of the Illumina Human CVD beadchip (version 1) on the Illumina BeadStation 500G were used for genotyping at The Centre for Applied Genomics (TCAG) (Hospital for Sick Children, Toronto, Ontario, Canada; www.tcag.ca). Briefly, ~200 ng (4 uL at 50 -70 ng/uL) of double-stranded genomic DNA was added to a whole genome amplification reaction producing fragments of approximately 1.5 -2 kb in length. Sixty-seven individuals (7.4%) were excluded because they were on lipid-lowering therapy and 11 individuals (1.3%) were excluded from the analysis due to genotype call rates <95%. 1151 SNPs (2.3%) by guest, on August 15, 2017 www.jlr.org
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were excluded from the analysis due to genotype call rates <95%. SNPs that were not in Hardy-Weinberg equilibrium (HWE) (P < 0.0001) or with a minor allele frequency <0.01 were excluded leaving 35 303, 31 751 and 35 018 SNPs in South Asian, Chinese, and Caucasian samples, respectively. Due to the marginal power of the SHARE sample and given the effect size of many of the recently reported associations, only SNPs that were prevalent in all three populations (MAF > 0.01) were included in the analysis. The intersection of these three population sets left 29 377 SNPs, which were studied in the final analyses.
Statistical methods
Pairwise identity-by-state (IBS) distance and multi-dimensional scaling, as implemented in PLINK (12) , was used to test for population stratification, sample duplication or contamination. In IBS, a similarity matrix is produced by computing the proportion of the number of alleles shared between all pairs of individuals. Reducing the number of dimensions by classical (metric) multi-dimensional scaling enables the subjects to be drawn on a 2 dimensional plot. All association analysis was performed in PLINK (12) . The reported linear regression significance is for a codominant model, testing for an additive effect of allele dosage, with the asymptotic P-value of the t-statistic reported using age, sex, BMI and ethnicity as covariates. The functional relevance or previous associations reported for the SNPs found on the CVD beadchip and the density of markers in the candidate loci renders the Bonferroni correction particularly over-conservative. FDR control is a statistical method, less conservative and more powerful than family wise error rate (FWER) control, used to correct for multiple comparisons and determine an appropriate significance threshold that reduces the probability of errors in the rejected hypotheses (15) . results from all 500,000 permutations of all the SNPs to calculate an empirical significance value as follows:
where P is the overall empirical P-value, p i is the empirical P-value and N i is the number of permutations in the i th instance of PLINK (12) . Since genotype data is unaffected, linkage disequilibrium between SNPs remains throughout permutations. Results of association and permutation were displayed using WGAViewer (16) .
RESULTS
Three distinct clusters were identified by IBS and multi-dimensional scaling ( Figure 1 ). Points were then colored by self-reported ethnicity and all but two individuals fell into their respective clusters.
The two individuals who did not cluster appropriately were removed from further analysis. Among the by guest, on August 15, 2017 www.jlr.org Downloaded from SHARE participants (Table 1) , 27 SNPs in 4 loci were associated with a lipoprotein trait at a Benjamini Hochberg FDR corrected significance (P < 2.27 x10 -6 , Figure 2 ). The strongest association was seen between two variants just upstream of the APOA5 gene and TG concentrations (rs651821 and rs662799; P = 5.5 x 10 -12 ). APOA5 lies within a cluster of apolipoprotein genes (APOA1/A4/A5/C3), resulting from an ancestral gene duplication event (17) , in which variants have been consistently reported to be associated with TG and HDL (2, 7) . Associations between SNPs within the LPL gene and TG (lead SNP: rs13702; P = 1.7 x 10 -6 ), the CETP gene and HDL concentrations (lead SNP: rs9939224; P = 6.2 x 10 -7 ), and the APOE gene and LDL (lead SNP: rs7412; P = 1.7 x 10 -6 ; see Supplementary Figure 1 for Q-Q plots) were also identified above the Benjamini Hochberg FDR threshold. No SNPs located outside of the previously reported loci were associated after Benjamini Hochberg FDR correction. After using max(T) permutation to empirically derive significance corrected for multiple testing, association of the APOA5 and LPL loci with TG, the CETP locus and HDL and the APOE locus and LDL remained (P < 0.05). The apparent signal to noise ratio improved after max(T) permutation (see Figure 2 ). The total CPU time for permutation analysis was >10 years (480 CPUs x 10 days).
Of the 40 lipoprotein associations previously reported, 32 were represented on the Illumina CVD beadchip and 22 of these loci contained a nominally associated SNP (P < 0.05). In a thorough examination of the linkage disequilibrium surrounding the previously reported SNPs, either the lead SNP, or the SNP reported to be strongest associated to a trait in a previously reported study, or its proxy, a nearby SNP correlated with the lead SNP, was associated in the same direction with the same lipid fraction in our multiethnic sample for 13 loci (P < 0.05; Tables 2, 3 Focusing on one locus recently discovered using the GWAS approach, the strength of association and the direction and size of the effect in the three populations in the SHARE sample appears to focus the region of association. In the CELSR2/PSRC1/SORT1 locus, the strongest association with plasma LDL was found centered over the PSRC1 and CELSR2 genes (rs657420, P = 0.0047; Figure 3 ). Nearby rs646776 and rs12740374 were found to be associated in the same direction with similar effect size to earlier reports (8) (9) (10) . Between PSRC1 and SORT1, a recombination hotspot has been reported (2) ( Figure   3 ), and towards SORT1 the effect of the minor allele becomes discordant between ethnicities.
In an effort to identify the cumulative effect of multiple risk alleles on plasma lipoprotein concentrations, and the total proportion of trait variation that can be explained by the replicated genetic factors in a multiethnic sample, we performed a multivariate linear regression. A model was created to include age, sex, BMI, and ethnicity as covariates, as well as the sum of the number of risk alleles at the replicated SNPs for each of the lipoprotein traits (for TG: rs662799, rs13702, rs7412, rs1748197, rs1260326, rs17145738; for HDL: rs9939224, rs651821, rs331, rs4775041, rs4149327, rs12726525, rs7120118; and for LDL: rs7412, rs6413504, rs657420, and rs3761739). It should be noted that many of the SNPs included in the model were not associated at the FDR threshold, but were previously reported and nominally associated in the SHARE sample (P < 0.05; Tables 2,3 associations with the same directionality indicating differences in association between ethnicities are more likely to be due to differences in allele frequencies or haplotype structures than differences in the real effect; and 2) the recently reported findings, while of great biological interest, are often not replicable in clinical-or modest-sized epidemiological samples, especially if a genome wide significance threshold is required. We do not believe that non-replication of the associations identified in the much larger GWAS studies reduces the credibility of their findings, but we underscore the importance of the associations that are robust to ethnicity and identifiable in a well-studied clinical research cohort of ~900 individuals.
The APOE ε2 / ε3 / ε4 isoform has long been associated with plasma lipid concentrations (18, 19) . Within the APOE locus, the most significantly associated SNP was rs7412, of which a T allele codes for an amino acid change from arginine to cysteine at position 158 guaranteeing an ε2 isoform.
Unfortunately, rs429358, which differentiates between ε3 and ε4 isoforms, was not included on the Illumina CVD beadchip, and thus rs7412 was evaluated in the same unbiased manner as all other SNPs on the array. With each additional copy of the T allele at rs7412, and thus each additional copy of the ε2 isoform, we observe a decrease in LDL cholesterol and an increase in TG concentration (P < 0.0005), consistent with previously reported results of ε2 being associated with lower LDL cholesterol and higher TG concentrations when compared to ε3 or ε4 isoforms. In a separate report, the APOE ε2 / ε3 / ε4 genotype was determined in the SHARE sample through restriction isotyping and was found to be associated with plasma lipoprotein concentrations in all three ethnicities, essentially following the ε2 / ε3 / ε4 gradient that has been observed historically in many other samples (20) . Interestingly, neither rs7412, nor rs429358 has been mentioned in any of the previous GWAS reports, and they are not included on Affymetrix Genome-Wide SNP 6.0 array.
What is the advantage of using a multiethnic sample? Differences in minor allele frequency and background trait variation between ethnicities lead to differences in power, and subsequently differences For example, in the CELSR2/PSRC1/SORT1 locus, a recombination hotspot has been reported (2) in the same region where discordance in the direction of association between ethnicities occurs in Figure   3 . One might expect the discordance of effect direction if an ancestral recombination occurred leaving opposite alleles linked with the causative variant in subsequent generations. Despite the previously reported associations over CELSR2 and PSRC1 (rs646776 and rs12740374) (3, 5, 9, 10), due to a more plausible functional role for SORT1 in LDL metabolism (3), attention towards CELSR2/PSRC1/SORT1 locus has been primarily focused on SORT1 (3). Caution is required due to the marginal nature of the Pvalues, but our work suggests that the causative variants responsible for the CELSR2/PSRC1/SORT1 association with LDL is more likely to lie within or near the CELSR2 or PSRC1 genes, ~ 25kb upstream of SORT1. If SORT1 is responsible for the variation in LDL cholesterol, it appears likely that the associated variant acts through a distant cis-acting element, telomeric to the putative recombination hotspot.
Computational requirements pose a clear impediment to permutation analysis of GWAS datasets.
A benefit of label-swapping permutations is that the LD structure between SNPs remains, thus removing the assumption that each SNP is an independent test, theoretically creating a less conservative correction (12) . Adaptive permutation has been proposed, in which SNPs are dropped from further permutation if they are clearly not associated. However, determining the appropriate significance threshold is still by guest, on August 15, 2017 www.jlr.org Downloaded from difficult and the problem of multiple-testing remains. In max(T) permutation using the PLINK "mperm" command, the significance can be compared to the distribution of possible regression results for all SNPs, more directly addressing the problem of multiple testing (12, 23) . Serial-farming, in which hundreds or thousands of CPUs perform the permutations on a large cluster, creates an environment in which largescale permutation analysis of GWAS datasets is possible. The true validity of permutation analysis is whether it can separate biologically valid associations from spurious associations more effectively than simply picking the next most significant P-value from a list of test statistics. Further application of permutation testing and downstream examination of results will be required. However, in this dataset, the results of 500 000 label-swapping max(T) permutations and a simple multiple testing correction were not very different. Our findings suggest that permutation analysis, while clarifying the "signal-to-noise" ratio of P-values across the range of SNPs evaluated, did not fundamentally change the conclusions from a
Benjamini Hochberg FDR corrected significance generated by the linear regression in PLINK. This suggests that such a computationally intensive analysis may not necessarily yield a substantial improvement.
Studies of coronary artery disease (24), type 2 diabetes (1), and hypertriglyceridemia (25) have reported an increased odds ratio for disease development with the cumulative number of risk alleles. The number of individuals observed decreases with each additional risk allele, as predicted by the minor allele frequencies, and the risk for disease increases, until the risk approaches Mendelian proportions (25) . One study in Caucasians showed that the number of lipoprotein risk alleles was associated with the quantitative differences in plasma LDL and HDL concentrations (24) . In a similar fashion, using our multiethnic sample and SNPs from replicated loci specific for the lipoprotein trait instead of a general lipid panel, we were able to show that a relationship exists between the cumulative number of risk alleles and plasma lipoprotein concentrations, with slightly larger effect than the earlier report. Moreover, the Clustering of IBS scores after multi-dimensional scaling reveals the three distinct population clusters in the SHARE sample. Two individuals did not cluster with self-reported ethnicity and were excluded from further analysis.
Fig. 2.
Manhattan plots of regression and permutation results. Each point represents the -log(P) value for a single SNP linear regression including age, sex, BMI, and ethnicity as covariates. Improvement of signal-to-noise ratio upon 500 000 label-swapping max(T) permutations is seen in the bottom three graphs, in which the corrected empirical p-values are reported. All points in the top graph are in the bottom graph, but the P-value of many points have approached 1. P < 2.2 x 10 -6 are highlighted in red in the top three graphs, P < 0.05 are highlighted in red in the bottom three graphs. Fig. 3 . Replication of association between the CELSR2/PSRC1/SORT1 locus and plasma LDL cholesterol concentrations. The upper bars depict the size and direction of the effect of the minor allele, coloured by population (using the β-coefficient on the left y-axis for scale). The lower bars depict the probability of SNP association (transformed by -log) in the complete sample with age, sex, BMI and ethnicity as covariates. The red line indicates a P-value of 0.05. The green star indicates a recombination hotspot and the red stars indicate SNPs which were previously reported as the holding the strongest association with LDL cholesterol. Fig. 4 . Regression analyses of the relationship between plasma lipoprotein concentration and the cumulative number of risk alleles from multiple replicated loci. Risk alleles include: rs662799, rs13702, rs7412, rs1748197, rs1260326, rs17145738 for TG; rs9939224, rs651821, rs331, rs4775041, rs4149327, rs12726525, rs7120118 for HDL; and rs7412, rs6413504, rs657420, rs3761739 for LDL. Lipoprotein measurements are in mmol/L. β-coefficient is the effect size of each additional risk allele standardized to the standard deviation of the trait, r 2 is the correlation between the lipid trait and the model including age, sex, BMI, ethnicity and number of risk alleles. The P-value represents the significance of the regression. 
